- Home
- BVS vs NXP Comparison
BVS vs NXP Comparison
Compare BVS & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVS | NXP |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.2M | 898.0M |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BVS | NXP |
|---|---|---|
| Price | $14.38 | $14.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 810.2K | 151.2K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $27.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.26 | $13.89 |
| 52 Week High | $15.89 | $14.65 |
Technical Indicators
Market Signals| Indicator | BVS | NXP |
|---|---|---|
| Relative Strength Index (RSI) | 61.47 | 43.35 |
| Support Level | $7.29 | $13.94 |
| Resistance Level | $15.89 | $14.51 |
| Average True Range (ATR) | 0.78 | 0.10 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 51.67 | 20.01 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About NXP Nuveen Select Tax Free Income Portfolio
Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund has single operating segment.